当前位置:首页 - 行情中心 - 金凯生科(301509) - 财务分析 - 利润表

金凯生科

(301509)

  

流通市值:12.44亿  总市值:49.75亿
流通股本:2150.83万   总股本:8603.33万

利润表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、营业总收入124,332,621.75766,824,305.02586,070,790432,034,126.07
营业收入124,332,621.75766,824,305.02586,070,790432,034,126.07
二、营业总成本110,839,890.09556,738,632.67419,790,484.02302,627,665.46
营业成本75,352,404.76404,847,560.97300,804,480.73228,214,702.56
税金及附加1,841,501.936,124,753.544,621,935.812,946,736.91
销售费用5,094,051.3325,477,463.9721,746,563.6413,581,794.87
管理费用24,277,215.6193,525,581.676,813,230.3347,324,086.61
研发费用6,964,404.4830,040,192.4819,440,285.0513,701,594.9
财务费用-2,689,688.02-3,276,919.89-3,636,011.54-3,141,250.39
其中:利息费用73,415.612,202,974.851,844,941.091,263,886.77
其中:利息收入1,008,882.363,883,906.842,536,904.71,217,156.5
加:投资收益1,596,683.034,752,765.041,714,865.241,223,728.73
资产处置收益--491,788.84--
资产减值损失(新)--12,750,133.761,353,194.781,353,194.78
信用减值损失(新)3,740,576.64-709,285.07-3,771,546.88-5,572,277.15
其他收益1,236,991.052,824,691.991,224,993.36197,435.37
营业利润平衡项目0000
四、营业利润20,066,982.38203,711,921.71166,801,812.48126,608,542.34
加:营业外收入10,545.3456,761.5743,872.63576,710.5
减:营业外支出6,258.79362,909.19371,383.56370,635.86
利润总额平衡项目0000
五、利润总额20,071,268.93203,405,774.09166,474,301.55126,814,616.98
减:所得税费用3,330,063.2229,831,607.7220,268,450.5514,919,639.54
六、净利润16,741,205.71173,574,166.37146,205,851111,894,977.44
持续经营净利润16,741,205.71173,574,166.37146,205,851111,894,977.44
归属于母公司股东的净利润16,741,205.71173,574,166.37146,205,851111,894,977.44
(一)基本每股收益0.192.422.191.73
(二)稀释每股收益0.192.422.191.73
八、其他综合收益264,604.892,531,856.684,792,370.415,889,977.18
归属于母公司股东的其他综合收益264,604.892,531,856.684,792,370.415,889,977.18
九、综合收益总额17,005,810.6176,106,023.05150,998,221.41117,784,954.62
归属于母公司股东的综合收益总额17,005,810.6176,106,023.05150,998,221.41117,784,954.62
归属于少数股东的综合收益总额---0
公告日期2024-04-242024-04-022023-10-242023-08-30
审计意见(境内)标准无保留意见
TOP↑